Added to YB: 2023-10-18
Pitch date: 2023-10-18
NMRA:US [bullish]
Neumora Therapeutics, Inc.
-78.59%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.
Market Cap
$442.8M
Pitch Price
$9.76
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.23
P/E
-1.81
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Neumora Therapeutics, Inc. NMRA:US
A summary for this pitch has not been created yet.
Read full article (0 min)